MYCOPHENOLATE MOFETIL (MMF) [900 MG/M2 Q8H] IN COMBINATION WITH TACROLIMUS IS EFFECTIVE TO PREVENT ACUTE AND CHRONIC GVHD IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS

被引：0
|
作者：
Militano, Olga [1 ]
Mitchell, Daniel [1 ]
Ours, Christopher [1 ]
Morris, Erin [1 ]
Wolownik, Karen [1 ]
Foley, Sandi [1 ]
LeClere, Jennie [1 ]
Vandeven, Carmella [1 ]
Cairo, Mitchell [1 ]
机构：
[1] New York Med Coll, Valhalla, NY 10595 USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S102 / S103
页数：2
相关论文
共 15 条
  • [1] Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic Gvhd Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
    Militano, Olga
    Mitchell, Daniel
    Ours, Christopher
    Morris, Erin
    Wolownik, Karen
    Foley, Sandra
    Leclere, Jennie
    van de Ven, Carmella
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S176 - S176
  • [2] PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL (MMF) IN COMBINATION WITH TACROLIMUS IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS ≤ 12 YEARS OF AGE
    Militano, O.
    Bhatia, M.
    Figurski, M.
    Shaw, L.
    Geyer, M. B.
    Jacobson, J. S.
    Morris, F.
    Satwani, P.
    George, D.
    Garvin, J. H.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S191 - S191
  • [3] Low Incidence of Grade II-IV Acute GVHD Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
    Militano, Olga
    Ozkaynak, M. Fevzi
    Mitchell, Daniel
    Wolownik, Karen
    Fabricatore, Sandra
    van de Ven, Carmella
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S369 - S370
  • [4] Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients
    Militano, O.
    Hedgpeth, D.
    Shaw, L. M.
    Figurski, M.
    Satwani, P.
    Ayello, J.
    Roman, E.
    Bradley, B.
    George, D.
    Garvn, J.
    Bhatia, M.
    Wolownick, K.
    Foley, S.
    Hawkes, R.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 114 - 115
  • [5] Higher clearance rates of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients
    Militano, O
    Roache, K
    Shaw, LM
    Figurski, M
    Satwani, P
    Ayello, J
    Roman, E
    Del Toro, G
    Bradley, B
    George, D
    Garvin, JH
    Bhatia, M
    Wolownik, K
    Foley, S
    Hawks, R
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 57 - 58
  • [6] TACROLIMUS AND Q8H MYCOPHENOLATE MOFETIL (MMF) PROPHYLAXIS IN CHILDREN AND YOUNG ADULT (CAYA) RECIPIENTS OF ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT) RESULTS IN AVERY LOW INCIDENCE OF GRADE II-IV ACUTE GVHD (AGVHD)
    Militano, Olga
    Ozkaynak, Mehmet Fevzi
    Adams, Debra
    Nickerson, Berkley
    van de Ven, Carmella
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 114 - 114
  • [7] Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Garvin, J
    George, D
    Bradley, MB
    DelToro, G
    Wischhover, C
    Wolownik, K
    van de Ven, C
    Cheung, YK
    Cairo, MS
    PEDIATRIC RESEARCH, 2003, 53 (04) : 528A - 528A
  • [8] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Cheung, YK
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 103 - 103
  • [9] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD.
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Skerrett, D
    Cairo, MS
    BLOOD, 2003, 102 (11) : 713A - 713A
  • [10] Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients are associated with significantly higher clearance
    Militano, O
    Roache, K
    Shaw, LM
    Figurski, M
    Satwani, P
    Ayello, J
    Wolownik, K
    Foley, S
    Hawkes, R
    Del Toro, G
    Bradley, MB
    George, D
    Garvin, J
    Bhatia, M
    Roman, L
    Cairo, MS
    BLOOD, 2005, 106 (11) : 518A - 518A
12